This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (12)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Monique S. Roy, MD; Robert F. Bonner, PhD; Peter M. Bungay, PhD; Marvin J. Podgor, MS; Bronwyn Collier, RN

Arch Ophthalmol. 1986;104(7):1004-1008.

Abstract
• We performed vitreous fluorophotometry using the Fluorotron Master and intravenous fluorescein injection of 14 mg/kg of body weight in 22 normal subjects. Various methods of analysis were used to evaluate vitreous fluorescein concentration at 3 mm from the retina as well as averaged over the posterior 6 mm. The various methods of calculation yielded mean (±SD) postinjection values ranging from 1.7 ± 1.4 to 4.3 ± 2.3 ng/mL at 30 minutes and from 7.1 ± 2.4 to 10.8 ± 2.7 ng/mL at 60 minutes. The permeability index determined 60 minutes after injection ranged from 0.92 ± 0.40 x 10^-7 to 1.19 ± 0.30 x 10^-7 cm/s, according to the protocol used. Replicate pairs of measurements in six subjects demonstrated that the procedure was reproducible to within 17% to 49%, depending on the analysis. The results suggest that if the current methods of data analysis are used, fluorescein leakage might be considered abnormally high if at 60 minutes the 3-mm posterior vitreous fluorescein concentration corrected for background fluorescence exceeds 14.3 ng/mL and/ or the permeability index exceeds 2 x 10^-7 cm/s.

Author Affiliations
From the Clinical Branch, Retinal and Vitreal Disease Section, National Eye Institute (Dr Roy and Ms Collier), the Biomedical Engineering and Instrumentation Branch, Division of Research Services (Drs Bonner and Bungay), and the Biometry and Epidemiology Program, National Eye Institute (Mr Podgor), National Institutes of Health, Bethesda, Md.

Footnotes
Accepted for publication Dec 9, 1985.

Reprint requests to Clinical Branch, Retinal and Vitreal Disease Section, National Eye Institute, National Institutes of Health, Bethesda, MD 20892 (Dr Roy).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Posterior Vitreous Fluorophotometry: I. Description of a New Analysis Procedure and Results in Normal Subjects
Bungay et al.
Arch Ophthalmol 1989;107:1321-1327.
ABSTRACT  

Posterior Vitreous Fluorophotometry: II. Comparison of Diabetic Patients and Controls With the Use of a New Analysis Procedure
Roy et al.
Arch Ophthalmol 1989;107:1328-1333.
ABSTRACT  

Color Vision Defects in Sickle Cell Anemia
Roy et al.
Arch Ophthalmol 1987;105:1676-1678.
ABSTRACT